01 2Aspen Pharmacare Holdings
02 1Cohance Lifesciences
03 32care4
04 5AFT Pharmaceuticals
05 1Acino Pharma
06 3Actavis Inc
07 4Arrotex Pharmaceuticals
08 4CHEMO
09 4DelNova Healthcare
10 4Janssen-Cilag
11 8Johnson & Johnson Innovative Medicine
12 5MEDICE ARZNEIMITT.PUETTER GmbH
13 11Medice Arzneimittel Pütter GmbH & Co KG
14 4Neos Therapeutics
15 7Novartis Pharmaceuticals Australia Pty Limited
16 5Novartis South Africa (Pty) Ltd
17 4Noven Pharmaceuticals
18 3ORIFARM GROUP AS
19 6SHIRE PLC
20 4Sandoz B2B
21 4Teva Pharma Australia
22 4Teva Pharmaceutical Industries
23 4Viatris
24 20Blank
01 6Antic-calc Tablet
02 4CAP
03 11Depottablett
04 1Extended Release Pellet
05 4Extended Release Tablet
06 7Extended-Release Tablet
07 8FILM, EXTENDED RELEASE;TRANSDERMAL
08 2Methylphenidate 10Mg 30 Joined' Oral Use Rm
09 2Methylphenidate 20Mg 30 Joined' Oral Use Rm
10 2Methylphenidate 30Mg 30 Joined' Oral Use Rm
11 1Methylphenidate 40Mg 30 Joined' Oral Use Rm
12 1Methylphenidate 5Mg 30 Joined' Oral Use Rm
13 11Modified Release Capsule
14 3Modified Release Tablet
15 4Osmotic Tablet
16 4Prolonged Release Tablet
17 1SRT
18 11TAB
19 7TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
20 6Tablet
21 24Blank
01 4DISCN
02 6Generic
03 10Originator
04 11RX
05 89Blank
01 1ACERTA 18
02 1ACERTA 27
03 1ACERTA 36
04 1ACERTA 54
05 1Adaphen
06 1Adaphen Xl
07 1Artige
08 4COTEMPLA XR-ODT
09 18Concerta
10 1Concerta 18Mg 30 Tablets Lib Prolonged
11 1Concerta 27Mg Extended Release Tablets 30
12 1Concerta 36Mg Extended Release Tablets 30
13 1Concerta 54Mg Extended Release Tablets 30
14 1Concerta®
15 4DAYTRANA
16 3Equasym
17 3Equasym Depot
18 7METHYLPHENIDATE
19 4METHYLPHENIDATE-TEVA XR
20 1Medicebran 10Mg 30 Tablets
21 1Medicebran 20Mg 30 Tablets
22 1Medicebran 5Mg 30 Tablets
23 17Medikinet
24 1Methylphenidate 30 18Mg Mylan Pharmaceuticals Compr Liber Prol Efg
25 1Methylphenidate Hcl - Douglas 10 Mg
26 1Methylphenidate Mylan Pharmaceuticals 36Mg 30 Compr Liber Prol Efg
27 1Methylphenidate Mylan Pharmaceuticals 54Mg 30 Compr Liber Prol Efg
28 4Methylphenidate Sandoz
29 1Methylphenidate Sandoz 18Mg Extended Release Tablets 30 Efg
30 1Methylphenidate Sandoz 27Mg Extended Release Tablets 30 Efg
31 1Methylphenidate Sandoz 36Mg Extended Release Tablets 30 Efg
32 1Methylphenidate Sandoz 54Mg Extended Release Tablets 30 Efg
33 1Methylphenidate Tecnigen 36Mg 30 Tablets Release Prolong Efg
34 1Methylphenidate Tecnigen 54Mg 30 Tablets Release Prolong Efg
35 1Methylphenidate Tecnigen Liberac 18Mg 30 Tablets Prolonged Efg
36 4Methylphenidate XR ARX
37 2Metylfenidat Aurora Medical
38 1Ritalin
39 1Ritalin 10
40 5Ritalin LA
41 2Ritalin La
42 1Ritalin La 10 Capsules
43 1Ritalin La 40
44 1Rubifen 10Mg 30 Tablets
45 1Rubifen 20Mg 30 Tablets
46 1Rubifen 5Mg 30 Tablets
47 5Rubifen LA
48 5Blank
01 24Australia
02 5India
03 8Italy
04 28Norway
05 16South Africa
06 24Spain
07 15USA
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Adaphen Xl
Dosage Form : SRT
Dosage Strength : 20mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Extended Release Pellet
Dosage Strength : 11%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Adaphen
Dosage Form : TAB
Dosage Strength : 10mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : DISCN
Registration Country : USA
Brand Name : METHYLPHENIDATE
Dosage Form : TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
Dosage Strength : 8.6MG
Packaging :
Approval Date : 2020-06-19
Application Number : 210924
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : METHYLPHENIDATE
Dosage Form : TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
Dosage Strength : 17.3MG
Packaging :
Approval Date : 2020-06-19
Application Number : 210924
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : METHYLPHENIDATE
Dosage Form : TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
Dosage Strength : 25.9MG
Packaging :
Approval Date : 2020-06-19
Application Number : 210924
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : COTEMPLA XR-ODT
Dosage Form : TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
Dosage Strength : 8.6MG
Packaging :
Approval Date : 2017-06-19
Application Number : 205489
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : COTEMPLA XR-ODT
Dosage Form : TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
Dosage Strength : 17.3MG
Packaging :
Approval Date : 2017-06-19
Application Number : 205489
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : COTEMPLA XR-ODT
Dosage Form : TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
Dosage Strength : 25.9MG
Packaging :
Approval Date : 2017-06-19
Application Number : 205489
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : COTEMPLA XR-ODT
Dosage Form : TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
Dosage Strength : 34.6MG
Packaging :
Approval Date : 2024-08-19
Application Number : 205489
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAYTRANA
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 10MG/9HR (1.1MG/HR)
Packaging :
Approval Date : 2006-04-06
Application Number : 21514
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAYTRANA
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 15MG/9HR (1.6MG/HR)
Packaging :
Approval Date : 2006-04-06
Application Number : 21514
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAYTRANA
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 20MG/9HR (2.2MG/HR)
Packaging :
Approval Date : 2006-04-06
Application Number : 21514
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAYTRANA
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 30MG/9HR (3.3MG/HR)
Packaging :
Approval Date : 2006-04-06
Application Number : 21514
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Equasym
Dosage Form : Methylphenidate 20Mg 30 Joined' Oral Use Rm
Dosage Strength : 30 cps 20 mg modified release
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Equasym
Dosage Form : Methylphenidate 30Mg 30 Joined' Oral Use Rm
Dosage Strength : 30 cps 30 mg modified release
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Equasym
Dosage Form : Methylphenidate 10Mg 30 Joined' Oral Use Rm
Dosage Strength : 30 cps 10 mg modified release
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : METHYLPHENIDATE
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 10MG/9HR (1.1MG/HR)
Packaging :
Approval Date : 2022-03-14
Application Number : 206497
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : METHYLPHENIDATE
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 15MG/9HR (1.6MG/HR)
Packaging :
Approval Date : 2022-03-14
Application Number : 206497
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : METHYLPHENIDATE
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 20MG/9HR (2.2MG/HR)
Packaging :
Approval Date : 2022-03-14
Application Number : 206497
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : METHYLPHENIDATE
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 30MG/9HR (3.3MG/HR)
Packaging :
Approval Date : 2022-03-14
Application Number : 206497
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Medikinet
Dosage Form : Methylphenidate 20Mg 30 Joined' Oral Use Rm
Dosage Strength : 30 cps 20 mg modified release
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Medikinet
Dosage Form : Methylphenidate 30Mg 30 Joined' Oral Use Rm
Dosage Strength : 30 cps 30 mg modified release
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Medikinet
Dosage Form : Methylphenidate 10Mg 30 Joined' Oral Use Rm
Dosage Strength : 30 cps 10 mg modified release
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Medikinet
Dosage Form : Methylphenidate 40Mg 30 Joined' Oral Use Rm
Dosage Strength : 30 cps 40 mg modified release
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Medikinet
Dosage Form : Methylphenidate 5Mg 30 Joined' Oral Use Rm
Dosage Strength : 30 cps 5 mg modified release
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Medicebran 10Mg 30 Tablets
Dosage Form : Tablet
Dosage Strength : 10 Mg/Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Rubifen 10Mg 30 Tablets
Dosage Form : Tablet
Dosage Strength : 10 Mg/Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Concerta 18Mg 30 Tablets Lib Prolonged
Dosage Form : Prolonged Release Tablet
Dosage Strength : 18 Mg/Prolonged Release Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Methylphenidate Sandoz 18Mg Extended Release Tablets 30 Efg
Dosage Form : Extended-Release Tablet
Dosage Strength : 18 Mg/Extended-release Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
